Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

1.

Assessing the Effects of Teriparatide Treatment on Bone Mineral Density, Bone Microarchitecture, and Bone Strength.

Kleerekoper M, Greenspan SL, Lewiecki EM, Miller PD, Kendler DL, Maricic M, Keaveny TM, Kopperdahl DL, Ruff VA, Wan X, Janos B, Krohn K.

J Bone Joint Surg Am. 2014 Jun 4;96(11):e90. [Epub ahead of print]

PMID:
24897747
2.

Secondary osteoporosis: endocrine and metabolic causes of bone mass deterioration.

Miazgowski T, Kleerekoper M, Felsenberg D, Stěpán JJ, Szulc P.

J Osteoporos. 2012;2012:907214. doi: 10.1155/2012/907214. Epub 2012 Feb 23. No abstract available.

3.

Evaluation of trabecular microarchitecture in nonosteoporotic postmenopausal women with and without fracture.

Kijowski R, Tuite M, Kruger D, Munoz Del Rio A, Kleerekoper M, Binkley N.

J Bone Miner Res. 2012 Jul;27(7):1494-500. doi: 10.1002/jbmr.1595.

4.

Clinical applications for vitamin D assays: what is known and what is wished for.

Kleerekoper M, Schleicher RL, Eisman J, Bouillon R, Singh RJ, Holick MF.

Clin Chem. 2011 Sep;57(9):1227-32. doi: 10.1373/clinchem.2010.154997. Epub 2011 Apr 18. No abstract available.

5.

Poststroke fractures in a bi-ethnic community.

Lisabeth LD, Morgenstern LB, Wing JJ, Sanchez BN, Zahuranec DB, Skolarus LE, Burke JF, Kleerekoper M, Smith MA, Brown DL.

J Stroke Cerebrovasc Dis. 2012 Aug;21(6):471-7. doi: 10.1016/j.jstrokecerebrovasdis.2010.11.009. Epub 2011 Feb 21.

6.

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.

Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, Kleerekoper M, Luckey MM, McClung MR, Pollack RP, Petak SM; AACE Osteoporosis Task Force.

Endocr Pract. 2010 Nov-Dec;16 Suppl 3:1-37. No abstract available.

PMID:
21224201
7.

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations.

Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, Kleerekoper M, Luckey MM, McClung MR, Pollack RP, Petak SM.

Endocr Pract. 2010 Nov-Dec;16(6):1016-9. No abstract available.

PMID:
21216723
8.

Reduced bone mineral density is not associated with significantly reduced bone quality in men and women practicing long-term calorie restriction with adequate nutrition.

Villareal DT, Kotyk JJ, Armamento-Villareal RC, Kenguva V, Seaman P, Shahar A, Wald MJ, Kleerekoper M, Fontana L.

Aging Cell. 2011 Feb;10(1):96-102. doi: 10.1111/j.1474-9726.2010.00643.x. Epub 2010 Nov 15.

9.

Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, Burger HG, Colditz GA, Davis SR, Gambacciani M, Gower BA, Henderson VW, Jarjour WN, Karas RH, Kleerekoper M, Lobo RA, Manson JE, Marsden J, Martin KA, Martin L, Pinkerton JV, Rubinow DR, Teede H, Thiboutot DM, Utian WH; Endocrine Society.

J Clin Endocrinol Metab. 2010 Jul;95(7 Suppl 1):s1-s66. doi: 10.1210/jc.2009-2509. Epub 2010 Jun 21. Review.

PMID:
20566620
10.

Changes in trabecular microarchitecture in postmenopausal women on bisphosphonate therapy.

Greenspan SL, Perera S, Recker R, Wagner JM, Greeley P, Gomberg BR, Seaman P, Kleerekoper M.

Bone. 2010 Apr;46(4):1006-10. doi: 10.1016/j.bone.2009.12.025. Epub 2010 Jan 4.

11.

An unsatisfactory report card.

Kleerekoper M.

Acta Neurol Scand. 2009 Nov;120(5):368-9. doi: 10.1111/j.1600-0404.2009.01225.x. No abstract available.

PMID:
19832775
12.

Fat embolism syndrome.

Stein PD, Yaekoub AY, Matta F, Kleerekoper M.

Am J Med Sci. 2008 Dec;336(6):472-7. doi: 10.1097/MAJ.0b013e318172f5d2.

PMID:
19092320
13.

Osteoporosis prevention and management: an evidence-based review.

Kleerekoper M, Gold DT.

Clin Obstet Gynecol. 2008 Sep;51(3):556-63. doi: 10.1097/GRF.0b013e3181809ae0. Review.

PMID:
18677150
14.

Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease.

Raggi P, Kleerekoper M.

Clin J Am Soc Nephrol. 2008 May;3(3):836-43. doi: 10.2215/CJN.02910707. Epub 2008 Mar 5. Review.

15.

Soy isoflavones in the management of postmenopausal osteoporosis.

Atmaca A, Kleerekoper M, Bayraktar M, Kucuk O.

Menopause. 2008 Jul-Aug;15(4 Pt 1):748-57. doi: 10.1097/gme.0b013e31815c1e7f. Review.

PMID:
18277912
16.

Risk of fractures after stroke.

Brown DL, Morgenstern LB, Majersik JJ, Kleerekoper M, Lisabeth LD.

Cerebrovasc Dis. 2008;25(1-2):95-9. Epub 2007 Dec 6.

PMID:
18057878
17.

Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes.

Guzmán CB, Zhao C, Deighton-Collins S, Kleerekoper M, Benjamins JA, Skafar DF.

J Neuroendocrinol. 2007 Dec;19(12):958-65.

PMID:
18001325
18.

Glucocorticoid-induced osteoporosis.

Berris KK, Repp AL, Kleerekoper M.

Curr Opin Endocrinol Diabetes Obes. 2007 Dec;14(6):446-50. Review.

PMID:
17982350
19.

How common are functional incidentalomas of the parathyroid gland?

Koenig K, Kleerekoper M.

Nat Clin Pract Endocrinol Metab. 2006 Jun;2(6):316-7. No abstract available.

PMID:
16932308
20.

Differential associations for menopause and age in measures of vitamin K, osteocalcin, and bone density: a cross-sectional exploratory study in healthy volunteers.

Lukacs JL, Booth S, Kleerekoper M, Ansbacher R, Rock CL, Reame NE.

Menopause. 2006 Sep-Oct;13(5):799-808.

PMID:
16912661
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk